In clinical treatment of triple negative breast cancer, programmed cell death protein 1(PD1) monoclonal antibody combined with albumin and paclitaxel has achieved good results in the treatment of breast cancer 2. The gene discussed is PDCD1; the disease is breast carcinoma.